Houston Methodist Study Finds CAR T-Cell Therapy Most Effective When Combined With Radiation to Prevent Cancer Recurrence

Houston Methodist researchers find that combining CAR T-cell therapy with radiation after surgery effectively stops triple-negative breast cancer from spreading.

By: AXL Media

Published: Mar 10, 2026, 12:39 PM EDT

Source: The information in this article was sourced from Houston Methodist

Overcoming Barriers in Solid Tumor Immunotherapy

Triple-negative breast cancer (TNBC) is widely regarded as one of the most aggressive and difficult-to-treat malignancies due to its high recurrence rate and lack of targeted receptors. While Chimeric Antigen Receptor (CAR) T-cell therapy has revolutionized the treatment of certain blood cancers, its application in solid tumors has been hindered by the hostile environment surrounding the cancer cells. However, a new study from the Houston Methodist Research Institute has identified a strategic combination of radiation and engineered immune cells that may finally break this deadlock.

Timing the Intervention for Maximum Efficacy

The research team, led by Gabriel Duda, Ph.D., discovered that the effectiveness of CAR T-cells is heavily dependent on the volume of cancer remaining in the body. In laboratory models, the therapy was most successful when administered shortly after the primary tumor had been surgically removed. At this stage, when only small, hard-to-detect clusters of cells remain, the engineered T-cells can more easily identify and eliminate the lingering cancer before it has the opportunity to colonize distant organs.

Radiation as a Sensitizer for Immune Attacks

One of the study's most significant findings is the role of radiation in making solid tumors more vulnerable. The researchers found that applying radiation to metastatic lesions appeared to enhance the T-cells' ability to penetrate and attack the cancer, even in cases that were previously unresponsive to immunotherapy. This combined approach not only slowed the growth of existing tumors but also significantly reduced the probability of the disease spreading to the lungs and liver, which are common sites for TNBC metastasis.